Abiopharma

News list

Director Galant Paul 🟢 acquired 41.0K shares (2 derivative) of GPGI, Inc. (GPGI) at $12.16 Transaction Date: Jun 11, 2026 | Filing ID: 001784

Full text

News bot June 15, 2026, 11:01 p.m.
🔍 Galant Paul (Director)

Company: GPGI, Inc. (GPGI)

Report Date: 2026-06-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 40,984
Detailed Transactions and Holdings:
- Acquired 30,738 shares of Stock Option (Right to Buy) at $12.16 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | equity_swap_involved: 0 | shares_owned_after: 30,738.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 10,246 shares of Stock Option (Right to Buy) at $12.16 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | equity_swap_involved: 0 | shares_owned_after: 10,246.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The Stock Options will vest in equal annual installments of 25% each, on June 11, 2027 and on the first, second, and third anniversaries thereof.
- F2: The Stock Options were issued pursuant to the Amended and Restated GPGI, Inc. Non-Employee Director Compensation Policy in lieu of the annual cash retainer of $50,000 at the Director's election.